Cargando…

Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions

OBJECTIVE: To determine the prevalence of SARS-CoV-2 virus infection among female workers who were restricted to working from home compared with those who continued to attend in-person work. METHODS: As part of national surveillance program, serum samples for SARS-CoV-2 antibody testing and nasophar...

Descripción completa

Detalles Bibliográficos
Autores principales: Alishaq, Moza, Nafady-Hego, Hanaa, Jeremijenko, Andrew, Al Ajmi, Jameela Ali, Elgendy, Mohamed, Al Ansari, Naser Ali Asad, Elgendy, Hamed, Abou-Samra, Abdul-Badi, Butt, Adeel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315056/
https://www.ncbi.nlm.nih.gov/pubmed/35903580
http://dx.doi.org/10.2147/IDR.S360241
_version_ 1784754467896295424
author Alishaq, Moza
Nafady-Hego, Hanaa
Jeremijenko, Andrew
Al Ajmi, Jameela Ali
Elgendy, Mohamed
Al Ansari, Naser Ali Asad
Elgendy, Hamed
Abou-Samra, Abdul-Badi
Butt, Adeel A
author_facet Alishaq, Moza
Nafady-Hego, Hanaa
Jeremijenko, Andrew
Al Ajmi, Jameela Ali
Elgendy, Mohamed
Al Ansari, Naser Ali Asad
Elgendy, Hamed
Abou-Samra, Abdul-Badi
Butt, Adeel A
author_sort Alishaq, Moza
collection PubMed
description OBJECTIVE: To determine the prevalence of SARS-CoV-2 virus infection among female workers who were restricted to working from home compared with those who continued to attend in-person work. METHODS: As part of national surveillance program, serum samples for SARS-CoV-2 antibody testing and nasopharyngeal swabs for SARS-CoV-2 PCR were obtained on 1636 female school staff and salon/spa workers who were restricted to work remotely (restricted group) and 1190 female health-care workers who continued in-person work (unrestricted group). RESULTS: Seropositivity rate was 5.1% among the restricted and 22.7% among the unrestricted group (P < 0.0001). Presence of symptoms at baseline (adjusted odds ratio [aOR], 2.88; 95% CI 2.09–3.97), contact with a confirmed case (aOR 2.34; 95% CI 1.37–3.98), and unrestricted work type (aOR 4.71; 95% CI 3.24–6.86) were associated with a higher risk of infection, while increasing age was associated with a lower risk of infection. CONCLUSION: Prevalence of SARS-CoV-2 infection as determined by seropositivity was higher among women who were not subject to workplace restrictions.
format Online
Article
Text
id pubmed-9315056
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93150562022-07-27 Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions Alishaq, Moza Nafady-Hego, Hanaa Jeremijenko, Andrew Al Ajmi, Jameela Ali Elgendy, Mohamed Al Ansari, Naser Ali Asad Elgendy, Hamed Abou-Samra, Abdul-Badi Butt, Adeel A Infect Drug Resist Original Research OBJECTIVE: To determine the prevalence of SARS-CoV-2 virus infection among female workers who were restricted to working from home compared with those who continued to attend in-person work. METHODS: As part of national surveillance program, serum samples for SARS-CoV-2 antibody testing and nasopharyngeal swabs for SARS-CoV-2 PCR were obtained on 1636 female school staff and salon/spa workers who were restricted to work remotely (restricted group) and 1190 female health-care workers who continued in-person work (unrestricted group). RESULTS: Seropositivity rate was 5.1% among the restricted and 22.7% among the unrestricted group (P < 0.0001). Presence of symptoms at baseline (adjusted odds ratio [aOR], 2.88; 95% CI 2.09–3.97), contact with a confirmed case (aOR 2.34; 95% CI 1.37–3.98), and unrestricted work type (aOR 4.71; 95% CI 3.24–6.86) were associated with a higher risk of infection, while increasing age was associated with a lower risk of infection. CONCLUSION: Prevalence of SARS-CoV-2 infection as determined by seropositivity was higher among women who were not subject to workplace restrictions. Dove 2022-07-21 /pmc/articles/PMC9315056/ /pubmed/35903580 http://dx.doi.org/10.2147/IDR.S360241 Text en © 2022 Alishaq et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Alishaq, Moza
Nafady-Hego, Hanaa
Jeremijenko, Andrew
Al Ajmi, Jameela Ali
Elgendy, Mohamed
Al Ansari, Naser Ali Asad
Elgendy, Hamed
Abou-Samra, Abdul-Badi
Butt, Adeel A
Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions
title Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions
title_full Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions
title_fullStr Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions
title_full_unstemmed Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions
title_short Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions
title_sort seroprevalence of sars-cov-2 infection among working women and impact of workplace restrictions
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315056/
https://www.ncbi.nlm.nih.gov/pubmed/35903580
http://dx.doi.org/10.2147/IDR.S360241
work_keys_str_mv AT alishaqmoza seroprevalenceofsarscov2infectionamongworkingwomenandimpactofworkplacerestrictions
AT nafadyhegohanaa seroprevalenceofsarscov2infectionamongworkingwomenandimpactofworkplacerestrictions
AT jeremijenkoandrew seroprevalenceofsarscov2infectionamongworkingwomenandimpactofworkplacerestrictions
AT alajmijameelaali seroprevalenceofsarscov2infectionamongworkingwomenandimpactofworkplacerestrictions
AT elgendymohamed seroprevalenceofsarscov2infectionamongworkingwomenandimpactofworkplacerestrictions
AT alansarinaseraliasad seroprevalenceofsarscov2infectionamongworkingwomenandimpactofworkplacerestrictions
AT elgendyhamed seroprevalenceofsarscov2infectionamongworkingwomenandimpactofworkplacerestrictions
AT abousamraabdulbadi seroprevalenceofsarscov2infectionamongworkingwomenandimpactofworkplacerestrictions
AT buttadeela seroprevalenceofsarscov2infectionamongworkingwomenandimpactofworkplacerestrictions